Pall Corporation Overview
Pro stress-test →Pall Corporation, headquartered in Port Washington, New York and a wholly owned subsidiary of Danaher Corporation since 2015, is a global supplier of filtration, separations and purification products. Founded in 1946, the company serves critical fluid management needs across life sciences and industrial manufacturing.
Strategic Profile
Pro stress-test →Pall's business is split into two broad groups: Life Sciences (c.51%) and Industrial (c.49%). In September 2022, it was announced that Pall Life Sciences will be merging with Cytiva to create a new Biotechnology Group within Danaher. In March 2026, Pall appointed Dr. Roland Folz as President, effective March 3, 2026.
Competitive Landscape
Pro stress-test →Pall competes in the global filtration and bioprocessing space against companies like Sartorius, Repligen, and Aspen Aerogels. Key competitive advantages include its portfolio of single-use bioreactors and tangential flow filtration systems, decades of manufacturing expertise, and support from Danaher's resources. The company serves both pharmaceutical development and large-scale industrial applications.
Industry Context
Pall Corporation operates in Bioprocessing filtration and separation systems.
Key facts
Founded: 1946 · Headquarters: Port Washington, New York · Employees: 5,001-10,000 · Revenue: $2.8B (FY2014 - most recent public data) · Market cap: N/A